Reversal of dabigatran requiring hemodialysis, fresh frozen plasma, and 2 doses of idarucizumab in a patient with acute kidney injury
Purpose A case report of dabigatran-associated coagulopathy that lasted for about 1 week after drug discontinuation despite use of several treatment measures is presented. Summary Life-threatening hemorrhage can occur in patients receiving dabigatran, a direct-acting oral anticoagulant. Idarucizumab...
Saved in:
| Main Author: | Sheikh-Taha, Marwan (author) |
|---|---|
| Format: | article |
| Published: |
2018
|
| Online Access: | http://hdl.handle.net/10725/11358 https://doi.org/10.1093/ajhp/zxy008 http://libraries.lau.edu.lb/research/laur/terms-of-use/articles.php https://academic.oup.com/ajhp/article-abstract/76/1/9/5257112 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Idarucizumab for Reversal of Dabigatran
by: Sheikh‑Taha, Marwan
Published: (2019) -
Idarucizumab, a humanized, monoclonal antibody fragment for immediate reversal of dabigatran
by: Kuyumjian, Yara
Published: (2015) -
Effect of Intermittent Nesiritide Administration on Kidney Function
by: Sheikh-Taha, Marwan
Published: (2012) -
Amino Acid Requirements in Critically Ill Patients with Acute Kidney Injury Treated with Continuous Renal Replacement Therapy
by: Btaiche, Imad F.
Published: (2008) -
Sepsis in hemodialysis patients
by: Abou Dagher, Gilbert
Published: (2015)